In conclusion, EGFR-related targets may become new targets for the treatment of GTN, but there is a lack of clinical studies on EGFR in GTN, and further research is needed to determine whether its related drugs have clinical application. The gene discussed is EGFR; the disease is gestational trophoblastic neoplasm.